Determination — Drugs on F1
(PB 87 of 2007)
as amended
made under subsection 85AB(1) of the
National Health Act 1953
This compilation was prepared on 1 October 2010
taking into account amendments up to PB 104 of 2010
Prepared by the Office of Legislative Drafting and Publishing,
Attorney‑General’s Department, Canberra
Determination — Drugs on F1 (PB 87 of 2007)
1. Commencement [see Note 1]
This instrument commences on 1 November 2007.
2. Drugs on F1
The listed drug “Abatacept” is on F1.
The listed drug “Ambrisentan” is on F1.
The listed drug “Amino acid formula with vitamins and minerals without valine, leucine and isoleucine with fat, carbohydrate and trace elements and supplemented with docosahexanoic acid” is on F1.
The listed drug “Amylopectin, modified long chain” is on F1.
The listed drug “Arginine with carbohydrate” is on F1.
The listed drug “Artemether with lumefantrine” is on F1.
The listed drug “Cinacalcet” is on F1.
The listed drug “Cystine with carbohydrate” is on F1.
The listed drug “Benzathine benzylpenicillin” is on F1.
The listed drug “Bevacizumab” is on F1.
The listed drug “Bortezomib” is on F1.
The listed drug “Desvenlafaxine” is on F1.
The listed drug “Duloxetine” is on F1.
The listed drug “Eletriptan” is on F1.
The listed drug “Essential amino acids formula with vitamins and minerals” is on F1.
The listed drug “Etravirine” is on F1.
The listed drug “Hydroxyethyl starch 130/0.4” is on F1.
The listed drug “Ibandronic acid” is on F1.
The listed drug “Isoleucine with carbohydrate” is on F1.
The listed drug “Lacosamide” is on F1.
The listed drug “Lanthanum” is on F1.
The listed drug “Lenalidomide” is on F1.
The listed drug “Methoxyflurane” is on F1.
The listed drug “Methylnaltrexone” is on F1.
The listed drug “Metoprolol succinate” is on F1.
The listed drug “Mupirocin” is on F1.
The listed drug “Natalizumab” is on F1.
The listed drug “Nebivolol” is on F1.
The listed drug “Paclitaxel, nanoparticle albumin-bound” is on F1.
The listed drug “Paliperidone” is on F1.
The listed drug “Phenylalanine with carbohydrate” is on F1.
The listed drug “Polyethylene glycol 400” is on F1.
The listed drug “Poly-l-lactic acid” is on F1.
The listed drug “Posaconazole” is on F1.
The listed drug “Pramipexole” is on F1.
The listed drug “Prasugrel” is on F1.
The listed drug “Raltegravir” is on F1.
The listed drug “Rizatriptan” is on F1.
The listed drug “Silver sulfadiazine” is on F1.
The listed drug “Sitaxentan” is on F1.
The listed drug “Sodium bicarbonate” is on F1.
The listed drug “Sorafenib” is on F1.
The listed drug “Sunitinib” is on F1.
The listed drug “Tamarindus indica seed polysaccharide” is on F1.
The listed drug “Teriparatide” is on F1.
The listed drug “Triglycerides, long chain with glucose polymer” is on F1.
The listed drug “Triptorelin” is on F1.
The listed drug “Tyrosine with Carbohydrate” is on F1.
The listed drug “Ustekinumab” is on F1.
The listed drug “Valine with carbohydrate” is on F1.
The listed drug “Valsartan” is on F1.
The listed drug “Varenicline” is on F1.
The listed drug “Voriconazole” is on F1.
The listed drug “Whey protein formula supplemented with amino acids, long chain polyunsaturated fatty acids, vitamins and minerals, and low in protein, phosphate, potassium and lactose” is on F1.
Notes to the Determination — Drugs on F1 (PB 87 of 2007)
Note 1
The Determination — drugs on F1 (PB 87 of 2007) (in force under section 85AB(1) of the National Health Act 1953) as shown in this compilation is amended as indicated in the Tables below.
Table of Instruments
Title | Date of FRLI Registration | Date of | Application, saving or |
PB 87 of 2007 | 8 Oct 2007 (see F2007L03951) | 1 Nov 2007 |
|
PB 13 of 2008 | 19 Dec 2007 (see F2007L04910) | 1 Jan 2008 | — |
PB 20 of 2008 | 15 Jan 2008 (see F2008L00042) | 1 Feb 2008 | — |
as amended by |
|
|
|
PB 22 of 2008 | 31 Jan 2008 (see F2008L00254) | (a) | — |
PB 29 of 2008 | 7 Feb 2008 (see F2008L00288) | 1 Mar 2008 | — |
PB 39 of 2008 | 11 Mar 2008 (see F2008L00703) | 1 Apr 2008 | — |
PB 58 of 2008 | 12 May 2008 (see F2008L01392) | 1 June 2008 | — |
PB 68 of 2008 | 10 June 2008 (see F2008L02059) | 1 July 2008 | — |
PB 132 of 2008 | 11 Dec 2008 (see F2008L04647) | 1 Jan 2009 | — |
PB 5 of 2009 | 14 Jan 2009 (see F2009L00046) | 1 Feb 2009 | — |
PB 15 of 2009 | 12 Feb 2009 (see F2009L00435) | 1 Mar 2009 | — |
PB 37 of 2009 | 20 Apr 2009 (see F2009L01445) | 1 May 2009 | — |
PB 51 of 2009 | 11 June 2009 (see F2009L02291) | 1 July 2009 | — |
PB 78 of 2009 | 18 Aug 2009 (see F2009L03151) | 1 Sept 2009 | — |
PB 99 of 2009 | 8 Oct 2009 (see F2009L03802) | 1 Nov 2009 | — |
PB 109 of 2009 | 20 Nov 2009 (see F2009L04284) | 1 Dec 2009 | — |
PB 7 of 2010 | 17 Feb 2010 (see F2010L00474) | 1 Mar 2010 | — |
PB 17 of 2010 | 17 Mar 2010 (see F2010L00675) | 1 Apr 2010 | — |
PB 38 of 2010 | 15 Apr 2010 (see F2010L00940) | 1 May 2010 | — |
PB 104 of 2010 | 24 Sept 2010 (see F2010L02538) | 1 Oct 2010 | — |
(a) Section 1 of PB 22 of 2008 provides as follows:
1. Commencement
This instrument commences at 8 pm on 31 January 2008.
Table of Amendments
ad. = added or inserted am. = amended rep. = repealed rs. = repealed and substituted | |
Provision affected | How affected |
S. 2........................ | am. PB 13, 20, 29, 39, 58, 68 and 132 of 2008; PB 5, 15, 37, 51, 78, 99 and 109 of 2009; PB 7, 17, 38 and 104 of 2010 |